Gene · 5754
Papers1,606
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,606
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecularly Built Ligands Degrade Membrane Receptors via Enhancing Their Accumulation in Lysosomes. | ACS Cent Sci | 2025 | 41473803 | PubTator, text mining | PubMed |
| Familial colorectal cancer: search for novel predisposition genes. | Hum Genomics | 2025 | 41469725 | PubTator, text mining | PubMed |
| Small extracellular vesicle-associated surface protein biomarkers: emerging roles, opportunities, and challenges in diagnostics. | Front Bioeng Biotechnol | 2025 | 41404198 | PubTator, text mining | PubMed |
| Identification of therapeutic targets for insomnia through genetic and plasma proteomic approaches. | Medicine (Baltimore) | 2025 | 41398839 | PubTator, text mining | PubMed |
| Hierarchical core-shell DNA condensates enable programmable information storage and encryption. | Nat Commun | 2025 | 41365900 | PubTator, text mining | PubMed |
| Rational Design of Aptamer-Guided Framework Nucleic Acid Delivery Platform for Cancer Radionuclide Theranostics. | ACS Nano | 2025 | 41172349 | PubTator, text mining | PubMed |
| Developing Superselective Homobivalent Ligands Differentiating Membrane Antigen Density by Exploring the Spatial Limit of the Bivalency on Cells. | Anal Chem | 2025 | 41097888 | PubTator, text mining | PubMed |
| Advances of extracellular vesicles isolation and detection frontier technology: from heterogeneity analysis to clinical application. | J Nanobiotechnology | 2025 | 41084034 | PubTator, text mining | PubMed |
| Electron-Shuttling Mechanisms Drive Proximity Labeling to Unveil Tumor Marker Characteristics in Ovarian Cancer from Clinical Samples. | Anal Chem | 2025 | 41082720 | PubTator, text mining | PubMed |
| Chemical Evolution of Double Covalent Aptamers for Sustained Protein Degradation and Improved Cytotoxicity in NK-Cell-Mediated Tumor Therapy. | J Am Chem Soc | 2025 | 41065179 | PubTator, text mining | PubMed |
| Crafting Immune-Cancer Cell Crosstalk via Modular Multilayer Logic DNA Nanoadaptors. | Angew Chem Int Ed Engl | 2025 | 41047832 | PubTator, text mining | PubMed |
| Expression of antibody-drug conjugate targets in soft tissue sarcomas. | ESMO Open | 2025 | 41046759 | PubTator, text mining | PubMed |
| Patient-Derived Tumor Organoids to Model Cancer Cell Plasticity and Overcome Therapeutic Resistance. | Cells | 2025 | 41002429 | PubTator, text mining | PubMed |
| AMIGO2 accelerates tumor progression by inducing a cancer stem cell-like phenotype. | Sci Rep | 2025 | 40998908 | PubTator, text mining | PubMed |
| An aptamer-drug conjugate for promising cancer therapy with comprehensive evaluation from rodents to non-human primates. | Signal Transduct Target Ther | 2025 | 40987771 | PubTator, text mining | PubMed |
| Profilin and Non-Canonical Wnt Signaling: Coordinating Cytoskeletal Dynamics from Development to Disease. | J Dev Biol | 2025 | 40981267 | PubTator, text mining | PubMed |
| Cytotoxicity of 212Pb-labeled anti-PTK7 antibody in 2D adherent and 3D multicellular bladder cancer models. | EJNMMI Radiopharm Chem | 2025 | 40885785 | PubTator, text mining | PubMed |
| Patient-Derived Organoid Biobanks for Translational Research and Precision Medicine: Challenges and Future Perspectives. | J Pers Med | 2025 | 40863456 | PubTator, text mining | PubMed |
| Widespread Proteomic Changes Observed in a Cohort of Neonates and Infants Undergoing Cardiopulmonary Bypass. | JACC Adv | 2025 | 40839908 | PubTator, text mining | PubMed |
| POSTN-Mediated Interplay of M1 Polarized Macrophage with Tendon-Derived Stem Cells to Drive Traumatic Heterotopic Ossification Formation through PTK7/ATK Signaling? | Adv Sci (Weinh) | 2025 | 40823759 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5754/papers?page=3